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article, and both should be considered ﬁrst author.Necrotizing soft tissue infections (NSTIs) can be deﬁned as
infections of any of the layers within the soft tissue compart-
ment (dermis, subcutaneous tissue, superﬁcial fascia or muscle);
they are rare, with about 500 to 1500 cases per year, but are
associated with high rate of mortality—between 16% and 24%
[1]. NSTIs are classiﬁed in three types [2]: type 1 is a poly-
microbial infection, type 2 is due to Streptococcus pyogenes or
Staphylococcus aureus, sometimes in association, and type 3 is
due to Gram-negative bacilli such as Vibrio spp. If Escherichia coli
is frequently isolated from type 1 NSTIs or Fournier gangrene,
it has been rarely reported in monomicrobial NSTIs [3].
However, E. coli is a versatile pathogen and may cause diverse
extraintestinal diseases. This particular capability is associated
with the acquisition of virulence attributes not present in
commensal strains. These virulence genes may encode adhesins,
invasins, siderophores, protectins and toxins which could
contribute to the fatal outcome [4].New Microbes and New Infections © 2015 The Authors. Published by El
This is an open access artiHere we report a fatal case of NSTI caused by a E. coli strain
belonging to the recently described phylogenetic group C [4]
and harbouring numerous virulence factors reported to be
part of a pathogenicity island (PAI) such as PAI IIJ96 [5] and
conserved virulence plasmidic region [4].
A 29-year-old woman was referred to our intensive care
unit for septic shock. She had a history of chronic ulcerative
pancolitis and autoimmune hepatitis complicated for 10 years
by cirrhosis (Child-Pugh C). She was treated with azathioprine
and corticosteroids (30 mg per day of prednisone). She con-
sulted at the emergency department for fever and left leg pain
during 4 days at home and reported diarrhoea during several
days. The patient developed septic shock 10 hours after her
admission. her temperature was 39.4°C. Her heart rate was
120 beats per minute; blood pressure was 70/50 mm Hg, and
oxygen saturation was 50% with signs of acute respiratory
distress. The Glasgow Coma Score was 8 without stiff neck.
Clinical examination revealed the presence of a 10 cm long
purpuric erythema of the posterior face of the left thigh. Me-
chanical ventilation was required, associated with large-volume
expansion and cathecholaminergic support by adrenaline. Car-
diac arrest occurred a few minutes after intubation; the low-
ﬂow time was 5 minutes. Biological examinations revealed
showed acute renal failure (creatinemia 204 μmol/L), increasedNew Microbe and New Infect 2015; 8: 109–112
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FIG. 2. Extensive debridement of cutaneous and subcutaneous tissues
up to fascia was performed.
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coagulation (platelets 40 × 109/L; D-dimer >10 000 ng/L; pro-
thrombin time 17%), leucopenia (3800 cells/mm3), hepatocel-
lular failure (factor V 30%, bilirubin 99 μmol/L), lactate level
16 mmol/L and C-reactive protein 13.4 mg/L.
A broad-spectrum antibiotic therapy with piperacillin–
tazobactam, vancomycin and amikacin was begun with the
addition of clindamycin 2 hours later. Bullae and superﬁcial
excoriations appeared and progressed rapidly, as did erythema
(Fig. 1). Leg and abdomen computed tomography was per-
formed, which revealed subcutaneous fat inﬁltration in her two
legs, without collection. Given the clinical, biological and
radiological elements, a diagnosis of NSTI was made, and the
patient underwent surgery 4 hours after her admission to the
intensive care unit because of the clinical severity. An extensive
debridement of cutaneous and subcutaneous tissues up to fas-
cias was performed, which were not necrotizing, according to
the surgeon.
All bacteriological samples (blood cultures, bullae and sur-
gical tissues) grew a wild-type strain of E. coli. The antibiotic
therapy was changed to cefotaxime. Continuous renal
replacement therapy was begun to treat anuric renal failure.
Continuous bleeding of the surgical wound resulted in hae-
morrhagic shock requiring massive transfusions, and the
disseminated intravascular coagulation got worse.
Twenty-four hours after surgery, the skin lesions were
extensive, and subcutaneous crackles appeared (Fig. 2). A sec-
ond surgery debridement was decided on. An extension of soft
tissue cellulitis on the whole thigh and the Scarpa area, a lake of
bleeding and necrotizing fascia were noted. Unfortunately, the
patient died during the surgery.
The E. coli strain was further characterized using methods
described previously [3,4]. The strain belonged to the newly
described phylogenetic group C, which contains extraintestinal
pathogenic E. coli strains [4]. The strain carried genes encodingFIG. 1. Purpuric erythema, with bullae and superﬁcial excoriations.
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salmochelin (iroN), the toxins hemolysin (hlyC) and cytotoxic
necrotizing factor 1 (cnf1), as well as the adhesin/invasin Hra
and the P ﬁmbriae pilin PapC. The four latter genes are known
to be characteristic of PAI IIJ96, a major virulence determinant
involved in highly sustained level of bacteraemia [5]. Because
group C strains may contain a conserved virulence plasmidic
region [4], we looked for genes speciﬁcally associated to this
region (hlyF, ompTp, etsC, iss), and all were positive.
The monomicrobial E. coli NSTIs are exceptional diseases. Li
et al. [6] reported only one case of E. coli monomicrobial NSTI
among 35 monomicrobial fasciitis caused by Gram-negative
bacteria. Eighteen case reports have been published in the
literature (Table 1); most of them occurred in immunocom-
promised or cirrhotic patients [3,6–11]. Thirteen patients died
(72%); all patients developed septic shock before death. Nine
patients (50%) had liver cirrhosis (Child-Pugh B or C), and 66%
died.
Cirrhosis increases the risk of severe bacterial infections
because of a failure of the immune system, including inEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 8, 109–112
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TABLE 1. Underlying disease and outcome of 18 cases of Escherichia coli necrotizing soft tissue infection published since 1994
Study Year Age (years) Sex Underlying disease Outcome Genotypic characteristics of strain
Castanet [7] 1992 77 F Cirrhosis D ND
72 M Cirrhosis A ND
Corredoira [11] 1994 65 F Cirrhosis Child-Pugh C A ND
76 F Cirrhosis Child-Pugh C A ND
Yoon [9] 1998 56 M Cirrhosis D ND
60 M Cirrhosis A ND
50 M Chronic renal failure D ND
Horowitz [8] 2004 53 M Cirrhosis Child-Pugh B, third-degree burns D ND
55 F Cirrhosis Child-Pugh C D ND
Li [6] 2006 29 M Nephritic syndrome A ND
Grimaldi [3] 2010 83 M Aplastic anemia A cnf1 positive, phylogenetic group B2
Shaked [10] 2012 52 F Cirrhosis D ND
61 M Cryoglobulinemia, immunosuppressed D ND
88 M Chronic obstructive pulmonary disease, congestive heart failure,
chronic renal failure
D ND
65 M B cell lymphoma, allogeneic bone marrow transplantation D cnf1 negative
75 F B cell lymphoma, treated with chemotherapy D cnf1 positive
65 M B cell lymphoma D cnf1 positive
91 M Multiple myeloma D ND
A, alive; D, dead; ND, not done.
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strains of Gram-negative bacteria [12,13]. The prevalence of
soft tissue infections in cirrhotic patients is between 2% and
11% [11]. The most common bacteria are Staphylococcus aureus
and Streptococcus pyogenes [13,14]. The typical skin lesion found
for these E. coli infections is bullae, whereas it is present in only
15% of all NSTIs [15].
Although our patient was immunocompromised, her strains
harboured numerous virulence factors. The search for 21
virulence factors was performed by PCR using previously
published primers and ampliﬁcation conditions [3]. As previ-
ously reported [3,10,16], the strain harboured genes charac-
teristic of PAI IIJ96, in particular cnf1. cnf1 has been showed to
induce in vivo dermal necrosis in rabbit [17] by trough activation
of the RhoGTPases [18]. This toxin was found in the E. coli
strain reported by Grimaldi et al. [3] and in 3 out 7 strains
reported by Shaked and Samra [10]. The combination of this
PAI and the conserved virulence plasmidic region, which have
been rarely reported, may explain in part the exceptional
severity of our case.
In conclusion, the patient, immunocompromised by both
liver cirrhosis (Child-Pugh C) and her treatment (azathioprine,
corticosteroids), experienced fatal NSTI caused by a virulent
strain of E. coli carrying numerous extraintestinal virulence
factors, notably cnf1. Physicians should be aware that E. coli
could be responsible for NSTIs, particularly in immunocom-
promised patients.Conﬂict of interestNone declared.New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf
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